In Vitro Evaluation of Mangiferin Nanoformulation for α-Amylase and α-Glucosidase Inhibitory Activity
International Journal of Drug Delivery Technology · 16.07.2026 · 16 (65s)
DOI: 10.25258/ijddt.16.65s.78 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 16.07.2026. Verfasst von Basant Khare und 7 weiteren Autor:innen.
Abstract (Originalsprache)
.
Zitieren
APA
Khare, B., Ashish, A., Sunkara, S. P., Vali, C. S., Sharma, R., Mart, J., M, A., & Raj, P. P. (2026). In Vitro Evaluation of Mangiferin Nanoformulation for α-Amylase and α-Glucosidase Inhibitory Activity. International Journal of Drug Delivery Technology, 16(65s). https://doi.org/10.25258/ijddt.16.65s.78
Vancouver
Khare B, Ashish A, Sunkara SP, Vali CS, Sharma R, Mart J, et al. In Vitro Evaluation of Mangiferin Nanoformulation for α-Amylase and α-Glucosidase Inhibitory Activity. International Journal of Drug Delivery Technology. 2026;16(65s). doi:10.25258/ijddt.16.65s.78
BibTeX
@article{Khare2026,
author = {Khare, Basant and Ashish, Ashish and Sunkara, Siva Prasad and Vali, C. Sadak and Sharma, Ramica and Mart, Joel and M, Atchaya and Raj, Pulla Prudvi},
title = {In Vitro Evaluation of Mangiferin Nanoformulation for α-Amylase and α-Glucosidase Inhibitory Activity},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {65s},
doi = {10.25258/ijddt.16.65s.78}
}
EUVIMED